Six-year retrospective comparison of GeneXpert MTB/RIF Ultra PCR and culture for pediatric tuberculosis diagnosis in non-sputum samples
Open Access
- 3 February 2026
- journal article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (2) , e0313525
Abstract
Diagnosing tuberculosis (TB) in children is challenging due to the paucibacillary nature of the disease and difficulty in obtaining sputum samples. This 6-year retrospective study compared the diagnostic performance of the GeneXpert MTB/RIF Ultra PCR (GX-MTB/R-U) assay, an improved version of the MTB/RIF PCR (GX-MTB/R) assay, with conventional mycobacterial culture in pediatric non-sputum samples. A total of 417 non-sputum samples from a tertiary pediatric facility underwent simultaneous GX-MTB/R-U and culture testing. Performance was evaluated using conventional culture as a gold standard, and clinical review was used to resolve discordant results. GX-MTB/R-U demonstrated 93.9% sensitivity and 97.9% specificity when culture was used as the gold standard. Eight samples positive by GX-MTB/R-U assay but negative by culture were confirmed as true positive using clinical review of the patients, increasing the sensitivity to 95.1% and specificity to 100%. GX-MTB/R-U demonstrated excellent diagnostic performance in comparison to conventional culture and microscopy, particularly for paucibacillary and extrapulmonary samples. Our study results support the use of GX-MTB/R-U assay as a frontline diagnostic tool in pediatric TB, with culture reserved for confirmation of negative PCR results and antibiotic susceptibility testing. IMPORTANCE: Delays or inaccuracies in tuberculosis (TB) diagnosis can lead to treatment delays, disease progression, and poor clinical outcomes. This study provides compelling evidence on the excellent diagnostic performance of the GeneXpert MTB/RIF Ultra (GX-MTB/R-U) assay in pediatric non-sputum samples compared to conventional culture, the current gold standard. By demonstrating high sensitivity and specificity, particularly in extrapulmonary samples, the findings of our study highlight the potential of GX-MTB/R-U as a frontline TB diagnostic tool. The use of this assay in clinical practice could improve early detection, ensure timely initiation of antibiotic treatment, ultimately improving pediatric TB management and outcomes.Keywords
This publication has 26 references indexed in Scilit:
- Low-complexity automated nucleic acid amplification tests for extrapulmonary tuberculosis and rifampicin resistance in adults and adolescentsCochrane Database of Systematic Reviews, 2025
- Performance of Xpert MTB/RIF ultra for the diagnosis of tuberculous meningitis in children using cerebrospinal fluidScientific Reports, 2025
- Xpert MTB/RIF Ultra outperformed the Xpert assay in tuberculosis lymphadenitis diagnosis: a prospective head-to-head cohort studyInternational Journal of Infectious Diseases, 2022
- Use of Xpert MTB/RIF Ultra assay on stool and gastric aspirate samples to diagnose pulmonary tuberculosis in children in a high-tuberculosis-burden but resource-limited area of ChinaInternational Journal of Infectious Diseases, 2022
- Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy studyJournal of Infection, 2018
- Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysisThe Lancet Respiratory Medicine, 2015
- Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in children: A prospective, multi-centre evaluationJournal of Infection, 2015
- Progress and challenges in childhood tuberculosisThe Lancet Infectious Diseases, 2013
- A current review of infection control for childhood tuberculosisTuberculosis, 2011
- New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospectsPaediatric Respiratory Reviews, 2011